Clinical Trial Update: Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC [NA]

View source ↗

Summary

Clinical trial update reporting dose escalation of bevacizumab with ambulatory blood pressure monitoring in patients with advanced non-squamous non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma
• Non-squamous Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Chicago | Conditions: Advanced Non-squamous Non-Small Cell Lung Cancer | NA | Status: COMPLETED | Results posted: 2019-11-18